Goldman Sachs Group Inc Direxion Daily S&P Biotech Bea Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Direxion Daily S&P Biotech Bea stock. As of the latest transaction made, Goldman Sachs Group Inc holds 11,711 shares of LABD stock, worth $79,166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,711
Previous 41,032
71.46%
Holding current value
$79,166
Previous $239,000
64.85%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding LABD
# of Institutions
28Shares Held
2.45MCall Options Held
1.07MPut Options Held
144K-
Virtu Financial LLC New York, NY1.3MShares$8.79 Million0.5% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA511KShares$3.46 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY225KShares$1.52 Million2.28% of portfolio
-
Jane Street Group, LLC New York, NY152KShares$1.03 Million0.0% of portfolio
-
Two Sigma Securities, LLC New York, NY61.2KShares$413,6640.06% of portfolio